about
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac deathImpact of clinical and genetic findings on the management of young patients with Brugada syndrome.Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study.Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome.Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant.Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.Characterization of SEMA3A-encoded semaphorin as a naturally occurring Kv4.3 protein inhibitor and its contribution to Brugada syndrome.The genetics underlying acquired long QT syndrome: impact for genetic screeningIdentification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndromeFGF12 is a candidate Brugada syndrome locus.Cardiac arrest and Brugada syndrome: Is drug-induced type 1 ECG pattern always a marker of low risk?[Clinical conditions associated with abnormal QT interval: clinical implications].The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia?Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene.Erratum: Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac deathA wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndromeA comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: Validation of the 2013 diagnostic criteriaA KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndromeCongenital long QT syndromeBiventricular Arrhythmogenic Cardiomyopathy: a paradigmatic case
P50
Q28294931-1E87CA74-AD5E-4C17-9FB4-211B56D50F1BQ33166854-DBBD5978-B1EF-4CF9-B056-97E3F900084BQ35661823-37F617E3-C81C-4A57-A846-3B3927C2AD68Q36467977-A2283A30-B1C5-40B4-92E6-1B7775F6A581Q36593290-EE12E554-5B57-4A8D-92EA-2BF46C598F81Q36761139-9407AF39-925A-4A46-AFD3-ED637D9A9E72Q37002977-29B7748E-1CE7-4769-9B0A-910E26B84992Q37023884-E07B27D9-D7E0-446F-86AE-E153CB09C9A8Q37396467-23ABEF35-30D1-43F1-AD4E-CE9529280DD2Q37407989-5EAE2405-FD9A-4DEB-88FB-E53650E1C8D3Q47814973-4F3C405B-312C-47C8-8E92-C20A8FB32AFEQ49030808-B490D91E-CC9A-4C13-9C75-CB97BFF448B4Q50070682-6D03BFA9-DFAF-4DFF-BE78-5A28DFCDCA61Q52717923-D9400D30-D1E1-4E80-BB4C-441C689A6945Q55422969-6C8C3195-DA97-4BC7-B2E9-0AAD751C18D5Q58010135-0B21760F-CF95-4E61-8405-56622DC6B537Q58010237-095B10E2-D6CD-44EA-8414-A22A1B08E46AQ58010637-F939606A-03A0-433B-90B1-B48570DD9AE4Q58010712-ECAAA5E9-2388-4953-8368-6C2C4ED1180CQ61850491-AE4259D2-E180-4DE3-9D2D-663B0A2C2C94
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Federica Dagradi
@ast
Federica Dagradi
@en
Federica Dagradi
@es
Federica Dagradi
@nl
type
label
Federica Dagradi
@ast
Federica Dagradi
@en
Federica Dagradi
@es
Federica Dagradi
@nl
prefLabel
Federica Dagradi
@ast
Federica Dagradi
@en
Federica Dagradi
@es
Federica Dagradi
@nl
P106
P1153
24472645600
P21
P31
P496
0000-0002-1090-3292